GeneCapture Awarded $1 Million U.S. ARMY-Funded Development Contract to Add Invasive Fungal Pathogen Probes to its Rapid Detection Panel

May 30

HUNTSVILLE, ALABAMA – GeneCapture, an emerging Point-of-Care infection diagnostics company, has been awarded a contract

funded by the U.S. Army and managed by the Medical Technology Enterprise Consortium (MTEC) to address a capability gap in

soldier health and readiness. The $1 million contract adds invasive fungal pathogen probes to the current bacterial and viral panel,

enhancing its platform capabilities in identifying and treating complex infections. Wound infections are often caused by multiple

pathogens, with invasive fungal infections generally being the hardest to diagnose and treat… Read story here.

GeneCapture Awarded $2.5 Million Contract to Provide Rapid Identification Solution for ‘Pathogen X’ Threats from Defense Threat Reduction Agency